Studying natural bacteria in head and neck cancer
Part of Cancer, Ear, nose & throat clinical trials.
This study looks at the natural bacteria in and around head and neck tumors compared to healthy tissue. The goal is to understand if these bacteria affect cancer growth and treatment. By participating, you help researchers learn more about this type of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be seeing an ear, nose, and throat doctor for a suspected head and neck cancer.
- You must be scheduled for a panendoscopy—a procedure to look inside your throat and airway.
- You cannot have taken antibiotics or steroid medications in the last 3 months.
- You cannot have a condition that weakens your immune system or be taking immune-suppressing drugs.
- You cannot be pregnant or unable to read and understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This trial looks for specific signs in your blood and tumor tissue that may show how well immunotherapy is working for recurrent or metastatic head and neck cancer. It aims to help doctors personalize treatment in the future.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study looks at tissue samples from patients who had surgery for head and neck or breast cancer. Researchers want to understand how certain immune cells in the tumor might affect the cancer, which could help improve treatments in the future.
This study looks at tumor samples from people with head and neck cancer to understand why some treatments stop working. By studying the tumor tissue, researchers hope to find better ways to treat this cancer in the future.
This study looks at the chemical signatures (metabolomics) in blood and tumor tissue from people with head and neck cancer. It aims to find markers that may help predict treatment response or tailor future care.
Hear when a new Squamous Cell Cancer of Head and Neck (SCCHN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.